Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
4.545
-0.085 (-1.84%)
Sep 15, 2025, 12:12 PM EDT - Market open
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $974.17 million as of September 15, 2025. Its market cap has increased by 353.56% in one year.
Market Cap
974.17M
Enterprise Value
884.58M
1-Year Change
353.56%
Ranking
Category
Stock Price
$4.55
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $974.17M, a decrease of -57.43%. That is a compound annual growth rate of -18.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 992.39M | 344.66% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | 2.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |